Home » Topics » BioWorld Science

BioWorld Science
RSS

Mydecine reports preclinical data supporting MYCO-003 for anxiety and PTSD

Sep. 23, 2021

Lymph dysfunction identified as potential metabolic target

Sep. 23, 2021

VaxEquity collaborates with AstraZeneca to progress saRNA platform technology

Sep. 23, 2021

Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis

Sep. 23, 2021

MDL-001 shown to protect mice against COVID-19-mediated weight loss

Sep. 23, 2021

AbCellera and Everest Medicines collaborate to discover therapeutic antibodies

Sep. 23, 2021

Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders

Sep. 23, 2021

Hexagon Bio raises funds to advance preclinical pipeline in oncology and infectious diseases

Sep. 23, 2021

BiVictriX completes two antibody discovery campaigns in support of BVX-001

Sep. 23, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...